Back to search results

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Epidermolysis Bullosa · Epidermolysis Bullosa Acquisita · Dystrophic Epidermolysis Bullosa · Recessive Dystrophic Epidermolysis Bullosa

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Stanford University, Redwood City, California, United States

    Contact: Study coordinator (Clinical Research Coordinator) · cimino@stanford.edu · 650-723-3439
    Contact: Principal Investigator (Matt P Marinkovich, MD)
Study leads

  • Matt P Marinkovich, MD

    Principal Investigator

    Associate Professor of Dermatology

View source on ClinicalTrials.gov(opens in a new tab)